Xenon Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: XENE insiders have only sold shares in the past 3 months.


Recent Insider Transactions

NasdaqGM:XENE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
31 Aug 22SellUS$16,817Robin SherringtonIndividual436US$38.57
16 Aug 22SellUS$6,775,149Simon PimstoneIndividual177,135US$39.15
08 Mar 22SellUS$1,320,747Simon PimstoneIndividual43,320US$30.55
08 Mar 22SellUS$824,561Simon PimstoneIndividual27,051US$30.80
04 Mar 22SellUS$473,591Robin SherringtonIndividual15,538US$31.05
21 Jan 22BuyUS$20,167Christopher KenneyIndividual700US$28.81
21 Jan 22BuyUS$20,167Christopher KenneyIndividual700US$28.81
06 Dec 21BuyUS$97,600Christopher Von SeggernIndividual4,000US$24.40
06 Dec 21BuyUS$97,600Christopher Von SeggernIndividual4,000US$24.40
15 Nov 21SellUS$550,061Simon PimstoneIndividual17,557US$31.33

Ownership Breakdown

What is the ownership structure of XENE?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders227,7450.4%
General Public3,099,6355.0%
Hedge Funds4,900,0007.9%
Institutions54,036,08386.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 47.7%.


Top Shareholders

Top 25 shareholders own 76.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.87%
Avoro Capital Advisors LLC
4,900,000$181.1m-1.71%3.29%
7.34%
FMR LLC
4,572,368$169.0m19.27%0.02%
7.05%
Driehaus Capital Management LLC
4,391,038$162.3m33.04%1.79%
6.2%
Capital Research and Management Company
3,857,482$142.6m22.72%0.01%
4.2%
BVF Partners L.P.
2,613,966$96.6m0%3.68%
4.08%
Polar Capital Holdings plc
2,540,059$93.9m15.98%0.5%
3.41%
Perceptive Advisors LLC
2,122,535$78.4m-11.98%2.3%
3.2%
Marshall Wace LLP
1,990,372$73.6m29.75%0.2%
2.98%
Lord, Abbett & Co. LLC
1,857,596$68.7m3.73%0.25%
2.94%
Holocene Advisors, LP
1,829,152$67.6m101.09%0.42%
2.92%
Pictet Asset Management Limited
1,819,476$67.2m37.29%0.06%
2.65%
Citadel Advisors LLC
1,648,039$60.9m14.36%0.09%
2.63%
Redmile Group, LLC
1,639,344$60.6m0%1.85%
2.56%
Commodore Capital LP
1,594,932$58.9m32.62%10.38%
2.13%
OrbiMed Advisors LLC
1,329,200$49.1m93.76%0.82%
1.8%
Rock Springs Capital Management LP
1,123,604$41.5m33.37%1.12%
1.79%
Samlyn Capital, LLC
1,116,436$41.3m77.01%0.81%
1.77%
Great Point Partners, LLC
1,104,334$40.8m20.04%7.9%
1.6%
Morgan Stanley, Investment Banking and Brokerage Investments
995,202$36.8m-30.87%0.01%
1.53%
Point72 Asset Management, L.P.
954,184$35.3m-57.03%0.1%
1.39%
BlackRock, Inc.
868,290$32.1m41.2%no data
1.39%
Candriam Luxembourg S.A.
863,140$31.9m42.84%0.11%
1.21%
Baker Bros. Advisors LP
751,639$27.8m0%0.16%
1.01%
Adage Capital Management, L.P.
630,000$23.3m-3.08%0.05%
0.96%
Tavistock Life Sciences
600,000$22.2m0%1.08%